GreenLight Biosciences Holdings (GRNA) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

GreenLight Biosciences Holdings

GRNA

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

45M

Biotechnology

0.30USD

-0.00 ( -0.03%)

Market Closed (as of Jul 21, 20:00 EDT)

Relative Strenght

Volume Buzz

-79%

Earning Acce

Yes

Dist 52w H.

95%

Quote Panel

Updated July 31, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
45.43M
Shares Outstanding
151.68M
Share in Float
Dividende
0

Earning Date
No Data
Price Target
0.2995
Average Volume
684804
Beta
1.440043

Range
0.177-5.9
Industry
Biotechnology
Website
https://greenlightbiosciences.com
Sector
Healthcare

Quote Panel

Updated July 31, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

7.12x

P/S Ratio

0.82x

P/B Ratio

1.7

Debt/Equity

-2616.8%

Net Margin

$-1.1

EPS

How GRNA compares to sector?

P/E Ratio

Fundamentals

Relative Strength

GRNA

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

GRNA

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Canaccord Genuity

initialise

Previous: Not converted

2022-12-08

Now: Buy

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.21

N/A

-0.23
vs -0.14

Q1.22

N/A

-0.34
vs -0.22

Q2.22

N/A

-0.42
vs -0.28

Q3.22

N/A

-0.27
vs -0.30

Q4.22

N/A

-0.26
vs -0.23

Q1.23

N/A

-0.19
vs -0.34

Sales Growth

YoY

Current

Estimates

Q4.21

NA vs NA

Q1.22

257K vs NA

Q2.22

1.7M vs NA

Q3.22

1.7M vs NA

Q4.22

2.9M vs NA

Q1.23

+1386%

3.8M vs 257K

Return on Equity

QoQ

Q2.21

-543%

-5.43
vs -4.26

Q3.21

+14%

0.14
vs -5.43

Q4.21

+35%

0.35
vs 0.14

Q1.22

-60%

-0.60
vs 0.35

Q2.22

-378%

-3.78
vs -0.60

Q3.22

-45%

-0.45
vs -3.78

Q4.22

-83%

-0.83
vs -0.45

Q1.23

-128%

-1.28
vs -0.83

Institutionnal Ownership

QoQ

Q4.21

1
vs NA

Q1.22

39
vs 1

3800%

Q2.22

49
vs 39

26%

Q3.22

57
vs 49

16%

Q4.22

60
vs 57

Q1.23

60
vs 60

Q2.23

45
vs 60

-25%

Earnings Growth

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Canaccord Genuity

initialise

Previous: Not converted

2022-12-08

Now: Buy

Market Cap
45.43M
Shares Outstanding
151.68M
Share in Float
Dividende
0

Earning Date
No Data
Price Target
0.2995
Average Volume
684804
Beta
1.440043

Range
0.177-5.9
Industry
Biotechnology
Website
https://greenlightbiosciences.com
Sector
Healthcare

Relative Strength

GRNA

Sector

GreenLight Biosciences Holdings

GRNA

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

45M

Biotechnology

0.30USD

-0.00 ( -0.03%)

Market Closed (as of Jul 21, 20:00 EDT)

Relative Strenght

Volume Buzz

-79%

Earning Acce

Yes

Dist 52w H.

95%

N/A

P/E Ratio

7.12x

P/S Ratio

0.82x

P/B Ratio

1.7

Debt/Equity

-2616.8%

Net Margin

$-1.1

EPS

How GRNA compares to sector?

P/E Ratio

Company Description

0.30USD

N/A

7.12x

0.82x

1.7

-2616.8%

$-1.1

Latest News

Latest News

Earnings Growth

Latest News

Company Description

0.30USD

N/A

7.12x

0.82x

1.7

-2616.8%

$-1.1